sarclisa
sanofi winthrop industrie - isatuximab - mielom multiplu - agenți antineoplazici - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
tritace plus 5 mg/25 mg
sanofi s.r.l. - italia - combinatii (ramiprilum+hydrochlorothiazidum) - compr. - 5mg/25mg - combinatii de inhibitori ai e.c.a. inhibitori ai e.c.a. si diuretice - combinati
iodomarin comprimate 100 mcg
berlin-chemie ag (menarini group) - amoxicillinum iodidum - comprimate - 100 mcg
lyxumia solutie injectabila in stilou injector preumplut 10 mcg/0,2 ml
sanofi-aventis groupe - lixisenatidum - solutie injectabila in stilou injector preumplut - 10 mcg/0,2 ml
lyxumia solutie injectabila in stilou injector preumplut 20 mcg/0,2 ml
sanofi-aventis groupe - lixisenatidum - solutie injectabila in stilou injector preumplut - 20 mcg/0,2 ml
eloxatin 5 mg ml 5 mg/ml concentrat pentru soluţie perfuzabilă
sanofi-aventis france - oxaliplatinum - concentrat pentru soluţie perfuzabilă - 5 mg/ml
eloxatin 5 mg ml 5 mg/ml concentrat pentru soluţie perfuzabilă
sanofi-aventis france - oxaliplatinum - concentrat pentru soluţie perfuzabilă - 5 mg/ml
hexoraletten n 5 mg+1,5 mg
mcneil products limited c/o johnson&johnson ltd. - combinatii (chlorhexidinum+benzocainum) - pastile - 5mg+1,5mg - medicamente pentru zona oro-faringiana antiseptice
tacrolimus sandoz 5 mg
lek pharmaceuticals d.d. - germania - tacrolimusum - caps. - 5mg - imunosupresoare inhibitori de calcineurina
fer rompharm solutie injectabila 100 mg/2 ml
rompharm company srl, sc - de fier (iii) hydroxidum cu polymaltosi complexe - solutie injectabila - 100 mg/2 ml